Analyst upgrades typically lead to a positive short-term reaction in the stock market as they reflect a positive change in the analyst's view on the company's future performance. The upgrade from Market Perform to Outperform by Leerink Partners suggests a strong confidence in Regenxbio's potential for growth or improvement, which could attract more investors and potentially drive up the stock price in the short term.